Edwards Lifesciences EBITDA Margin 2010-2024 | EW
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Edwards Lifesciences (EW) over the last 10 years. The current EBITDA margin for Edwards Lifesciences as of December 31, 2024 is .
| Edwards Lifesciences EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $6.34B | $1.77B | 27.95% |
| 2024-06-30 | $6.23B | $1.79B | 28.73% |
| 2024-03-31 | $6.14B | $1.68B | 27.38% |
| 2023-12-31 | $6.01B | $1.68B | 27.98% |
| 2023-09-30 | $5.35B | $1.61B | 30.11% |
| 2023-06-30 | $5.42B | $1.65B | 30.33% |
| 2023-03-31 | $5.50B | $1.84B | 33.43% |
| 2022-12-31 | $5.38B | $1.89B | 35.08% |
| 2022-09-30 | $5.36B | $1.81B | 33.78% |
| 2022-06-30 | $5.36B | $1.80B | 33.58% |
| 2022-03-31 | $5.36B | $1.88B | 35.13% |
| 2021-12-31 | $5.23B | $1.83B | 34.87% |
| 2021-09-30 | $5.10B | $1.80B | 35.37% |
| 2021-06-30 | $4.93B | $1.76B | 35.75% |
| 2021-03-31 | $4.48B | $1.04B | 23.20% |
| 2020-12-31 | $4.39B | $1.01B | 22.91% |
| 2020-09-30 | $4.37B | $0.96B | 21.88% |
| 2020-06-30 | $4.32B | $0.89B | 20.59% |
| 2020-03-31 | $4.48B | $1.32B | 29.53% |
| 2019-12-31 | $4.35B | $1.24B | 28.43% |
| 2019-09-30 | $4.15B | $0.92B | 22.06% |
| 2019-06-30 | $3.97B | $0.87B | 21.87% |
| 2019-03-31 | $3.82B | $0.85B | 22.21% |
| 2018-12-31 | $3.72B | $0.83B | 22.18% |
| 2018-09-30 | $3.64B | $1.14B | 31.28% |
| 2018-06-30 | $3.55B | $1.12B | 31.46% |
| 2018-03-31 | $3.45B | $1.11B | 32.31% |
| 2017-12-31 | $3.44B | $1.17B | 34.10% |
| 2017-09-30 | $3.32B | $1.04B | 31.27% |
| 2017-06-30 | $3.23B | $1.00B | 31.02% |
| 2017-03-31 | $3.15B | $0.97B | 30.73% |
| 2016-12-31 | $2.96B | $0.86B | 28.89% |
| 2016-09-30 | $2.87B | $0.85B | 29.80% |
| 2016-06-30 | $2.74B | $0.81B | 29.68% |
| 2016-03-31 | $2.60B | $0.75B | 28.64% |
| 2015-12-31 | $2.49B | $0.71B | 28.39% |
| 2015-09-30 | $2.44B | $0.69B | 28.19% |
| 2015-06-30 | $2.43B | $0.66B | 27.22% |
| 2015-03-31 | $2.39B | $0.63B | 26.49% |
| 2014-12-31 | $2.32B | $0.56B | 24.20% |
| 2014-09-30 | $2.24B | $0.54B | 24.02% |
| 2014-06-30 | $2.13B | $0.51B | 24.10% |
| 2014-03-31 | $2.07B | $0.52B | 25.06% |
| 2013-12-31 | $2.05B | $0.54B | 26.15% |
| 2013-09-30 | $2.02B | $0.55B | 26.98% |
| 2013-06-30 | $1.97B | $0.53B | 26.93% |
| 2013-03-31 | $1.94B | $0.50B | 25.81% |
| 2012-12-31 | $1.90B | $0.47B | 24.96% |
| 2012-09-30 | $1.82B | $0.42B | 23.09% |
| 2012-06-30 | $1.78B | $0.39B | 21.58% |
| 2012-03-31 | $1.73B | $0.37B | 21.06% |
| 2011-12-31 | $1.68B | $0.36B | 21.32% |
| 2011-09-30 | $1.64B | $0.35B | 21.51% |
| 2011-06-30 | $1.58B | $0.36B | 22.83% |
| 2011-03-31 | $1.51B | $0.36B | 23.63% |
| 2010-12-31 | $1.45B | $0.34B | 23.57% |
| 2010-09-30 | $1.40B | $0.32B | 23.11% |
| 2010-06-30 | $1.38B | $0.32B | 22.84% |
| 2010-03-31 | $1.35B | $0.31B | 22.59% |
| 2009-12-31 | $1.32B | $0.30B | 22.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $42.914B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $210.506B | 96.57 |
| Thermo Fisher Scientific (TMO) | United States | $202.042B | 24.50 |
| Alcon (ALC) | Switzerland | $44.047B | 29.47 |
| IDEXX Laboratories (IDXX) | United States | $37.709B | 43.46 |
| DexCom (DXCM) | United States | $35.463B | 55.00 |
| IQVIA Holdings (IQV) | United States | $34.295B | 19.00 |
| Mettler-Toledo (MTD) | United States | $27.400B | 31.83 |
| Waters (WAT) | United States | $22.520B | 31.95 |
| STERIS (STE) | Ireland | $21.977B | 25.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.361B | 0.00 |
| Hologic (HOLX) | United States | $14.588B | 15.74 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.679B | 14.04 |
| Sysmex ADR (SSMXY) | Japan | $11.343B | 35.57 |
| Penumbra (PEN) | United States | $11.081B | 100.24 |
| Globus Medical (GMED) | United States | $10.896B | 25.48 |
| Masimo (MASI) | United States | $9.140B | 44.23 |
| Teleflex (TFX) | United States | $8.250B | 13.16 |
| Glaukos (GKOS) | United States | $6.850B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.269B | 23.96 |
| PROCEPT BioRobotics (PRCT) | United States | $3.400B | 0.00 |
| Veracyte (VCYT) | United States | $3.050B | 55.44 |
| LivaNova (LIVN) | United Kingdom | $2.688B | 15.52 |
| Nihon Kohden (NHNKY) | Japan | $2.652B | 14.49 |
| TransMedics (TMDX) | United States | $2.588B | 82.04 |
| Elekta AB (EKTAY) | Sweden | $2.198B | 19.76 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.701B | 8.89 |
| Alphatec Holdings (ATEC) | United States | $1.526B | 0.00 |
| RxSight (RXST) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.174B | 0.00 |
| Artivion (AORT) | United States | $1.167B | 111.40 |
| Pulse Biosciences (PLSE) | United States | $1.154B | 0.00 |
| Paragon 28 (FNA) | United States | $1.092B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.883B | 0.00 |
| AxoGen (AXGN) | United States | $0.793B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.791B | 17.30 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.718B | 12.21 |
| IRadimed (IRMD) | United States | $0.699B | 36.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.694B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.449B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.446B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.411B | 9.04 |
| AngioDynamics (ANGO) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.404B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.86 |
| CVRx (CVRX) | United States | $0.343B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.234B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Accuray (ARAY) | United States | $0.212B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.121B | 0.00 |
| LENSAR (LNSR) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| InspireMD (NSPR) | Israel | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.093B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.085B | 12.98 |
| Lucid Diagnostics (LUCD) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.58 |
| Microbot Medical (MBOT) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |